The U.S. Food and Drug Administration (FDA) has granted Regenerative Medicine Advanced Therapy (RMAT) designation to two research projects funded by the California Institute for Regenerative Medicine (CIRM). RMAT is a fast‑track designation that speeds the development, review, and potential approval of treatments for serious or life‑threatening diseases. The first RMAT designation went to a … Continue reading Two CIRM-funded research projects receive RMAT designation from FDA
Month: November 2024
Remembering CIRM board member and ALS patient advocate Fred Fisher
CIRM honors the contributions of Fred Fisher, MSW, LCSW, a dedicated member of our Independent Citizens’ Oversight Committee (ICOC) and an enthusiastic patient advocate. Fred passed away in September. He joined the ICOC as the ALS patient advocate in June 2021 and served in many roles, including co‑chair of the Standards Working Group and member … Continue reading Remembering CIRM board member and ALS patient advocate Fred Fisher
Celebrating 20 Years of Progress: CIRM’s 2024 Annual Report
This year marks an important milestone for the California Institute for Regenerative Medicine (CIRM)—20 years of accelerating innovation in regenerative medicine. To celebrate this achievement, we are excited to release the 2024 Annual Report, “Our Journey Forward: How CIRM Catalyzes Regenerative Medicine Today and Beyond.” For two decades, CIRM has played a pivotal role in … Continue reading Celebrating 20 Years of Progress: CIRM’s 2024 Annual Report
CIRM Welcomes New Board Members
The California Institute for Regenerative Medicine (CIRM) is thrilled to welcome a distinguished group of new board members and alternates, each bringing a wealth of experience and leadership in healthcare, research, and innovation. Joyce A. Sackey, MD, FACP Dr. Sackey joins CIRM as an alternate for Linda Boxer. As the inaugural Chief Equity, Diversity, and … Continue reading CIRM Welcomes New Board Members
UCLA researchers exploring ways to prevent heart failure after heart attacks
ENPP1 is expressed in the region of scarring after injury to the heart. Cardiac muscle shown in red and ENPP1 in green demonstrates expression of ENPP1 in the region of scar formation. | Credit: Arjun Deb Lab/UCLA At the California Institute for Regenerative Medicine (CIRM), we support cardiovascular research from Discovery through Clinical to advance … Continue reading UCLA researchers exploring ways to prevent heart failure after heart attacks
California advancing our understanding of Alzheimer’s disease using stem cells
More than 14,000 people in Fresno County live with Alzheimer’s, and an estimated 720,000 Californians face the disease statewide. That’s why the California Institute for Regenerative Medicine (CIRM)—the state agency funding regenerative medicine research—joined the Alzheimer’s Association Walk to End Alzheimer’s in Fresno/Madera to highlight the cell and gene therapy research we support. More than … Continue reading California advancing our understanding of Alzheimer’s disease using stem cells